DOCSLIB.ORG

Curriculum Vitae

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curriculum Vitae CURRICULUM VITAE David Randal Hessl, Ph.D. Department of Psychiatry and Behavioral Sciences and MIND Institute University of California Davis Medical Center 2825 50th Street Sacramento, CA 95817 (916) 703-0249 [email protected] EDUCATION Ph.D. University of Washington. Seattle, WA (1997) Major Area: Child Clinical Psychology Minor Area: Developmental Psychology Advisor: Geraldine Dawson, Ph.D. M.S. University of Washington. Seattle, WA (1995) Major Area: Child Clinical Psychology B.A. University of California, Los Angeles. Los Angeles, CA (1989) Major: Psychology ADDITIONAL TRAINING 1996 – 1997 APA Accredited Internship. Lucile Salter Packard Children’s Hospital at Stanford and The Children’s Health Council Consortium, Stanford and Palo Alto, CA. 1997 - 1998 MacArthur Foundation Post-Doctoral Fellowship. Institute of Human Development, University of California, Berkeley, CA. ACADEMIC POSITIONS 2014 – present Professor of Clinical Psychiatry. Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA. 2008 – 2014 Associate Professor of Clinical Psychiatry. Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA. David R. Hessl, PhD, 2 2006 – 2008 Assistant Professor of Clinical Psychiatry. Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA. 2003 – 2006 Assistant Clinical Professor. Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA. 2002 – 2003 Psychologist II. MIND Institute, University of California Davis School of Medicine, Sacramento, CA. 1998 - 2001 Research and Clinical Psychologist. Behavioral Neurogenetics Research Center, Division of Child Psychiatry, Stanford University School of Medicine, Stanford, CA. ACADEMIC AWARDS AND FELLOWSHIPS 1988 Honors in Psychology, University of California, Los Angeles 1991-1996 NIMH Graduate Student Research Fellowship, University of Washington 1994 Department of Psychology Dissertation Award, University of Washington 1997-1998 MacArthur Foundation Post-Doctoral Fellowship, Institute of Human Development, University of California, Berkeley 2003 Joe P. Tupin Research Award, Department of Psychiatry, U.C. Davis 2004 Co-Recipient, National Fragile X Foundation Hagerman Award, for contribution to the discovery of Fragile X-Associated Tremor/Ataxia Syndrome 2006 U.C. Davis Imaging Research Center Award 2007-2008 MIND Institute Pilot Research Grant Award 2008 U.C. Davis Academic Senate Research Travel Award 2008 U.C. Davis finalist – John Merck Scholars Program, Biology of Developmental Disabilities in Children 2009 Dean’s Team Award for Excellence, U.C. Davis School of Medicine 2012 Jarrett Cole Clinical Award, National Fragile X Foundation, for “Dedicated Service to Families in the Worldwide Fragile X Community” COMMITTEES AND SERVICE 2004 - Member, Human Development Graduate Group, UC Davis 2009 - Scientific and Clinical Advisory Board, National Fragile X Foundation 2008 - 2011 Member, Admissions Committee, U.C. Davis School of Medicine 2011 - 2014 Member, Committee on Student Progress, U.C. Davis School of Medicine 2008 - 2010 Co-Chair, Interview Subcommittee, Admissions Committee, U.C. Davis School of Medicine David R. Hessl, PhD, 3 2009 University of California, Davis Health System Centennial Event Panelist, Cornell Club, New York, NY and Capitol Visitor Center, Washington, DC 2010 - 2012 Member, Town Hall Committee, MIND Institute, U.C. Davis 2010 - 2011 Member, Research IV Planning Committee, U.C. Davis School of Medicine 2011 - 2014 Member, Committee on Student Progress, U.C. Davis School of Medicine 2013 - Specialty Advisor, UC Davis School of Medicine 2014 - 2015 Member, Committee on Research, UC Davis School of Medicine 2014 - Member, Clinical Trials Committee, Fragile X Clinical and Research Consortium 2015 - Member, Neuroscience Graduate Group, UC Davis 2015 Special Emphasis Panel, Centers for Disease Control and Prevention, “Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome to Improve Services and Outcomes” 2014 - Faculty Mentor, MIND Institute International Training Program in Neurodevelopmental Disorders (ITPND), UC Davis 2016 Ad Hoc Reviewer, Board of Scientific Counselors, National Institute of Mental Health 2016 - Faculty Welfare Committee, UC Davis 2016 - Child and Family Care Administrative Advisory Committee, UC Davis PANELS AND ADVISORY POSITIONS Member, Adolescents and Adults Projects Team, National Fragile X Foundation Reviewer, Social Sciences and Humanities Research Council of Canada Member, NIH Fragile X Research Coordinating Group Member, Fragile X Clinical & Research Consortium Executive Council Advisory Panelist, NICHD Outcome Measures for Clinical Trials with Children with Fragile X Syndrome Invited Participant, NIH Research Plan for Fragile X Syndrome and Associated Disorders (2008) Panelist, “How to Develop an Interdisciplinary Program of Research”, NIH Interdisciplinary Training Conference on Developmental Disabilities, Annapolis, MD Invited Participant, NIH Research Plan for Fragile X Syndrome and Associated Disorders (2012) Clinical Trials Consultant, Hoffman LaRoche Clinical Trials Consultant, Novartis Clinical Trials Consultant, Seaside Therapeutics Invited Expert Panelist, “The Future of Fragile X: Center for Disease Control Public Health Research Agenda”, Atlanta (2014) COMMUNITY SERVICE “A Conversation Between a Researcher and a Parent of a Child with Autism”, Access To Care, Bayside Church, Roseville, CA David R. Hessl, PhD, 4 Donation of an in-home evaluation of a child with fragile X syndrome in Iowa, to benefit the National Fragile X Foundation, 2007 Donation of an in-home evaluation of two children with fragile X syndrome in Missouri, to benefit the National Fragile X Foundation, 2008 Donation of an in-home evaluation a child with fragile X syndrome in Mississippi, to benefit the National Fragile X Foundation, 2011 Provided consultation in an autism clinic, in association with the First Annual Autism Conference, Dubai, United Arab Emirates, 2005 ACADEMIC PROFESSIONAL SERVICE Editorial Board Member – Journal of Neurodevelopmental Disorders Co-Editor, Special Issue on Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) – The Clinical Neuropsychologist (2016) Ad Hoc Reviewer Acta Psychiatrica Scandinavica American Journal on Intellectual and Developmental Disabilities American Journal of Medical Genetics Part B:Neuropsychiatric Genetics American Journal of Psychiatry Annals of Neurology Autism Research Behavior Genetics Behavioral Brain Research Brain and Cognition Clinical Genetics Genes, Brain and Behavior Biological Psychiatry Child Development Development and Psychopathology International Journal of Psychophysiology Journal of Autism and Developmental Disorders Journal of Child Psychology and Psychiatry Journal of Intellectual Disability Research Neuropsychology Pediatrics Psychoneuroendocrinology The Clinical Neuropsychologist PROFESSIONAL AFFILIATIONS American Psychological Association David R. Hessl, PhD, 5 Division 33 (Intellectual and Developmental Disabilities) – American Psychological Association LICENSURE Licensed Psychologist, State of California, #16690, 2000 - present MENTORING AND TEACHING Dissertation Chair for Alyssa Chavez, Department of Human Development, U.C. Davis Dissertation Co-Chair for Susannah Cohen, Department of Human Development, U.C. Davis Mentor to Paula Wadell-Weinstein, M.D., Psychiatry Resident, U.C. Davis School of Medicine Mentor to Lisa Cordeiro, Department of Human Development, U.C. Davis Mentor to Laurie Vismara, Ph.D., Autism Research Training Program, MIND Institute Mentor to Lisa Litt, Ph.D., Autism Research Training Program, MIND Institute Mentor to Andrea Schneider, Ph.D., Post-Doctoral Fellow, MIND Institute Co-Facilitator, Doctoring, U.C. Davis School of Medicine Faculty Member, Autism Research Training Program (PIs David Amaral and Sally Rogers) Mentor to Stephanie Sansone (Maltas), Department of Human Development, U.C. Davis, National Science Foundation Graduate Research Fellowship Program, “The Fragile X Premutation and Differential Susceptibility to Immune Dysfunction: Examination of a Possible Gene- Environment Interaction with Chronic Stress” Psy.D. Clinical Internship Supervisor to Amy Gaines Psy.D. Clinical Internship Supervisor to Corrisa Jacomini Dissertation Committee Chair, Stephanie Sansone, Human Development, UC Davis Dissertation Committee Member, Emily Halkett, Psychology, UC Davis Mentor to Rebecca Shields, Human Development graduate student, UC Davis Dissertation Committee Member, Abbie Poppa, Neuroscience Graduate Group, UC Davis Mentor, International Training Program in Neurodevelopmental Disorders, Ying Han (China) Mentor, International Training Program in Neurodevelopmental Disorders, Ariadna Ramírez Mallafré (Spain) Chair, Master’s Thesis Committee, Rebecca Shields, Human Development, UC Davis GRANTS AND OTHER SUPPORT Active NICHD – 1R01HD076189 A Cognitive Test Battery for Intellectual Disabilities Role: PI Amount: $3,145,326 total for 5 years Active The John Merck Fund: Developmental Disabilities Translational Research Grant Cognitive Training for Fragile X Syndrome Role: PI David R. Hessl, PhD, 6 Amount: $1,000,000 total for 4 years Active NIMH - 2R01MH078041-06 Trajectories and
Load more

Recommended publications
  • Sema4 Noninvasive Prenatal Select
    Sema4 Noninvasive Prenatal Select Noninvasive prenatal testing with targeted genome counting 2 Autosomal trisomies 5 Trisomy 21 (Down syndrome) 6 Trisomy 18 (Edwards syndrome) 7 Trisomy 13 (Patau syndrome) 8 Trisomy 16 9 Trisomy 22 9 Trisomy 15 10 Sex chromosome aneuploidies 12 Monosomy X (Turner syndrome) 13 XXX (Trisomy X) 14 XXY (Klinefelter syndrome) 14 XYY 15 Microdeletions 17 22q11.2 deletion 18 1p36 deletion 20 4p16 deletion (Wolf-Hirschhorn syndrome) 20 5p15 deletion (Cri-du-chat syndrome) 22 15q11.2-q13 deletion (Angelman syndrome) 22 15q11.2-q13 deletion (Prader-Willi syndrome) 24 11q23 deletion (Jacobsen Syndrome) 25 8q24 deletion (Langer-Giedion syndrome) 26 Turnaround time 27 Specimen and shipping requirements 27 2 Noninvasive prenatal testing with targeted genome counting Sema4’s Noninvasive Prenatal Testing (NIPT)- Targeted Genome Counting analyzes genetic information of cell-free DNA (cfDNA) through a simple maternal blood draw to determine the risk for common aneuploidies, sex chromosomal abnormalities, and microdeletions, in addition to fetal gender, as early as nine weeks gestation. The test uses paired-end next-generation sequencing technology to provide higher depth across targeted regions. It also uses a laboratory-specific statistical model to help reduce false positive and false negative rates. The test can be offered to all women with singleton, twins and triplet pregnancies, including egg donor. The conditions offered are shown in below tables. For multiple gestation pregnancies, screening of three conditions
    [Show full text]
  • Structural and Numerical Changes of Chromosome X in Patients with Esophageal Atresia
    European Journal of Human Genetics (2014) 22, 1077–1084 & 2014 Macmillan Publishers Limited All rights reserved 1018-4813/14 www.nature.com/ejhg ARTICLE Structural and numerical changes of chromosome X in patients with esophageal atresia Erwin Brosens*,1,2,5, Elisabeth M de Jong1,2,5, Tahsin Stefan Barakat3, Bert H Eussen1, Barbara D’haene4, Elfride De Baere4, Hannah Verdin4, Pino J Poddighe1, Robert-Jan Galjaard1, Joost Gribnau3, Alice S Brooks1, Dick Tibboel2 and Annelies de Klein1 Esophageal atresia with or without tracheoesophageal fistula (EA/TEF) is a relatively common birth defect often associated with additional congenital anomalies such as vertebral, anal, cardiovascular, renal and limb defects, the so-called VACTERL association. Yet, little is known about the causal genetic factors. Rare case reports of gastrointestinal anomalies in children with triple X syndrome prompted us to survey the incidence of structural and numerical changes of chromosome X in patients with EA/TEF. All available (n ¼ 269) karyotypes of our large (321) EA/TEF patient cohort were evaluated for X-chromosome anomalies. If sufficient DNA material was available, we determined genome-wide copy number profiles with SNP array and identified subtelomeric aberrations on the difficult to profile PAR1 region using telomere-multiplex ligation-dependent probe amplification. In addition, we investigated X-chromosome inactivation (XCI) patterns and mode of inheritance of detected aberrations in selected patients. Three EA/TEF patients had an additional maternally inherited X chromosome. These three female patients had normal random XCI patterns. Two male EA/TEF patients had small inherited duplications of the XY-linked SHOX (Short stature HOmeoboX-containing) locus.
    [Show full text]
  • Example Document Medical Genetics Center
    รายงานผลการตรวจววเคราะหย เลขทธรออางอนง : 00000 ศผนยยพวนธธศาสตรยการแพทยย 6/6 หมนม 6 ถนนสสขาภนบาล 5 ซอย 32 แขวงออเงนน เขตสายไหม กรสงเทพมหานคร 10220 Accreditation No.4148/57 โทรศกพทย/โทรสาร 086-8861203, 02-7920726 e-mail : [email protected] www.genetics.co.th ชชชอ น.ส............................. HN. ............. โรงพยาบาล .................................... ววนททชเกกบตววอยยาง 19 พฤศจนกายน 2558 12:55 แพทยยผผผสวชงตรวจ นพ.................................... ววนททชรวบตววอยยาง 20 พฤศจนกายน 2558 12:43 ววธทการตรวจ G-banding ชนวดตววอยยาง นนนาครรนา ขผอบยงชทชในการตรวจ Elderly Pregnancy หนยวยสยงตรวจ ไมมมธ Center document Genetics ผลการตรวจExample: 47,XXX คคาอธวบาย : ตรวจพบโครโมโซม 47 โครโมโซม,เปปนเพศหญนง,พบโครโมโซม X เกนนมา 1 โครโมโซม เขอาไดอกกบ Triple X Syndrome Medical หมายเหตธ: Band level 450 band ขผอจคากวดในการทดสอบ: ไมมสามารถตรวจสอบความผนดปกตนขนาดเลลกชนนด submicroscopic rearrangement หรรอ low-level mosaicism ไดอ ผผผรวบรองผล ( .................................. ) ววนททชออกรายงาน : ....................................... นพ.วทรยธทธ ประพวนธยพจนย,พบ.,วว.กธมารเวชศาสตรย American Board of Medical Genetics (Clinical Cytogenetics) Medical Genetics Center : Fo-QP-19/01 : 16-03-2015 : 02 เรียน อ.นพ...................................... ที่นับถือ ตามที่ผลตรวจโครโมโซมจากน ้าคร่้าของ นส........................ (HN .............., Lab no. ..............) พบ โครโมโซม X เกินมา 1 โครโมโซมนั น ความผิดปกติดังกล่าว เข้าได้กับกลุ่มอาการ trisomy X หรือ triple X syndrome ซึ่งเป็นความผิดปกติของโครโมโซมเพศที่พบได้บ่อยในทารกเพศหญิง โดยความผิดปกติของ โครโมโซมแบบนี
    [Show full text]
  • Inside This Issue
    Winter 2014 No. 77 Inside this issue Group News | Fundraising | Members’ Letters | One Family Living with Two Different Chromosome Disorders | Bristol Conference 2014 | Unique Leaflets | Christmas Card Order Form Sophie, Unique’s Chair of Trustees Dear Members, In the past month a few things have reminded me of why it is so important to make connections through Unique but also to draw support from other parents around us. I’ve just returned from Unique’s most recent family conference in Bristol where 150 of us parents and carers had a lovely time in workshops, meals and activities, chatting and watching our children milling around together like one big family since – although we had never met before – we have shared so many experiences in common. However in contrast I have also just met a new mum who has just moved to my area from far away with two toddlers, one with a rare joys of the internet, it is becoming easier to meet others with similar, chromosome disorder, who is starting from scratch with no even very rare, chromosome disorders around the world and to find professional, medical or social support. She reminds me of how yourself talking to them in the middle of the night about some lonely I felt when Max was newly diagnosed, when I knew no one interesting things our children share in common (obsession with with a disabled child let alone anyone with a rare chromosome catalogues, anyone?) And of course we also have an enormous disorder. Elsewhere our latest Unique Facebook group, Unique amount in common with so many parents of children with other Russia, is also just starting up – so far it includes just a small special needs or disabilities around us in our own communities who number of members sharing very different experiences to mine here will often be walking the same path as us.
    [Show full text]
  • Prenatal Diagnosis by FISH of a 22Ql 1 Deletion in Two Families J Med Genet: First Published As 10.1136/Jmg.35.2.165 on 1 February 1998
    I Med Genet 1998;35:165-168 165 Prenatal diagnosis by FISH of a 22ql 1 deletion in two families J Med Genet: first published as 10.1136/jmg.35.2.165 on 1 February 1998. Downloaded from Marie-France Portnoi, Nicole Joye, Marie Gonzales, Suzanne Demczuk, Laurent Fermont, Gilles Gaillard, Guy Bercau, Genevieve Morlier, Jean-Louis Taillemite Abstract balanced translocation t(I 1;22)(q23;ql 1) was We report on prenatal diagnosis by FISH shown in the father's karyotype; in the second of a sporadic 22qll deletion associated case trisomy X was associated with a 22ql 1 with DiGeorge syndrome (DGS) in two deletion in the fetus. fetuses after an obstetric ultrasonographic examination detected cardiac anomalies, Materials and methods an interrupted aortic arch in case 1 and KARYOTYPING AND FISH tetralogy of Fallot in case 2. The parents Fetal blood samples were obtained for karyo- decided to terminate the pregnancies. At type analysis and FISH. Cells were harvested necropsy, fetal examination showed char- from cultures of phytohaemagglutinin stimu- acteristic facial dysmorphism associated lated lymphocytes and spread onto slides for with congenital malformations, confirm- the production of G banded or R banded chro- ing full DGS in both fetuses. In addition to mosomes. the 22ql 1 deletion, trisomy X was found in FISH of metaphase chromosomes using dig- the second fetus and a reciprocal balanced oxigenin labelled cosmid probes D22S75 translocation t(l 1 ;22) (q23;ql 1) was found (N25, ONCOR) from the DGS chromosome in the clinically normal father of case 1. region was carried out basically according to These findings highlight the importance Pinkel et al.' This probe was premixed with a of performing traditional cytogenetic control cosmid (D22S39) in 22q13.3 facilitat- analysis and FISH in pregnancies with a ing chromosome identification.
    [Show full text]
  • Double Aneuploidy in Down Syndrome
    Chapter 6 Double Aneuploidy in Down Syndrome Fatma Soylemez Additional information is available at the end of the chapter http://dx.doi.org/10.5772/60438 Abstract Aneuploidy is the second most important category of chromosome mutations relat‐ ing to abnormal chromosome number. It generally arises by nondisjunction at ei‐ ther the first or second meiotic division. However, the existence of two chromosomal abnormalities involving both autosomal and sex chromosomes in the same individual is relatively a rare phenomenon. The underlying mechanism in‐ volved in the formation of double aneuploidy is not well understood. Parental ori‐ gin is studied only in a small number of cases and both nondisjunctions occurring in a single parent is an extremely rare event. This chapter reviews the characteristics of double aneuploidies in Down syndrome have been discussed in the light of the published reports. Keywords: Double aneuploidy, Down Syndrome, Klinefelter Syndrome, Chromo‐ some abnormalities 1. Introduction With the discovery in 1956 that the correct chromosome number in humans is 46, the new area of clinical cytogenetic began its rapid growth. Several major chromosomal syndromes with altered numbers of chromosomes were reported, such as Down syndrome (trisomy 21), Turner syndrome (45,X) and Klinefelter syndrome (47,XXY). Since then it has been well established that chromosome abnormalities contribute significantly to genetic disease resulting in reproductive loss, infertility, stillbirths, congenital anomalies, abnormal sexual development, mental retardation and pathogenesis of malignancy [1]. Clinical features of patients with common autosomal or sex chromosome aneuploidy is shown in Table 1. © 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • Female Polysomy-X and Systemic Lupus Erythematosus
    Seminars in Arthritis and Rheumatism 43 (2014) 508–512 Contents lists available at ScienceDirect Seminars in Arthritis and Rheumatism journal homepage: www.elsevier.com/locate/semarthrit Female polysomy-X and systemic lupus erythematosus Mordechai Slae, MDa,n, Merav Heshin-Bekenstein, MDb, Ari Simckes, MDb, Gali Heimer, MDb, Dan Engelhard, MDb, Eli M. Eisenstein, MDc a Department of Pediatrics, University of Alberta Hospital, Edmonton, Alberta, Canada b Department of Pediatrics, Hadassah-Hebrew University Hospital at Ein Kerem, Jerusalem, Israel c Department of Pediatrics, Hadassah-Hebrew University Hospital at Mount-Scopus, Jerusalem, Israel article info abstract Objectives: Systemic lupus erythematosus (SLE) occurs more commonly in females than in males. Recent Keywords: evidence suggests that genetic factors transmitted by the X-chromosome may confer increased risk for Gene dosage autoimmune disease in general, and for SLE in particular. It is therefore possible that X-chromosome Lupus genetics polysomy might confer further increased risk for lupus. In addition to describing the clinical and Polysomy-X immunologic features of a young woman with polysomy-X and SLE, we sought to review all other Sex differences published cases associating female or male polysomy-X with SLE or other forms of autoimmunity. SLE Methods: We report a case of a prepubertal girl with polysomy-X and SLE. We performed a systemic X-chromosome literature review for cases of polysomy-X and SLE and summarize previously published cases. In addition, we reviewed reports concerning the possible association between SLE and other connective tissue diseases and male polysomy-X. Results: An 11-year-old girl with tetrasomy-X (48 XXXX karyotype) presented with prolonged fever.
    [Show full text]
  • Original Article
    Original article AN UNUSUAL CASE OF DOUBLE ANEUPLOIDY OF DOWN SYNDROME ASSOCIATED WITH TRIPLE X SYNDROME: 48,XXX,+21 A.Uwineza1, J.Hitayezu1, S.Murorunkwere1, J.Ndinkabandi1, L.Mutesa1,* 1Center for Medical Genetics, Faculty of Medicine, National University of Rwanda, Butare, Rwanda. ABSTRACT Down syndrome is the most common chromosomal abnormality in humans with an estimated incidence of one case in 770 live births. However, the occurrence of double aneuploidy involving autosome and or sex chromosome is a very rare phenomenon in lives born and the majority of reported cases are presented in form of spontaneous abortions. Here, we are reporting a case of a Rwandan patient with combination of trisomy 21 and triple X syndrome. The proband was 8-month-old female with typical features of Down syndrome. In additional to Down syndrome features, the child presented with minor features of triple X syndrome characterized by hypotonia and seizures. Keywords: Double aneuploidy - Down syndrome - Triple X syndrome - 48, XXX,+21 RESUME La trisomie 21 ou syndrome de Down est la plus fréquente anomalie chromosomique chez l’homme avec une incidence estimée à 770 cas de nouveau- nés vivants dans le monde. Cependant, la survenue d’une double anomalie chromosomique aneuploide intéressant les chromosomes autosomes ou chromosomes sexuels est un événement très rare et la majorité des cas rapportés sont liés à des formes de fausses couches spontanées. Nous rapportons ici un cas d’un patient Rwandais portant une double aneuploidie de trisomie 21 et le syndrome de Triple X; (48,XXX,+21). Le proband était un sujet de sexe féminin âgé de 8 mois présentant des symptômes typiques du syndrome de Down.
    [Show full text]
  • Early ACCESS Diagnosed Conditions List
    Iowa Early ACCESS Diagnosed Conditions Eligibility List List adapted with permission from Early Intervention Colorado To search for a specific word type "Ctrl F" to use the "Find" function. Is this diagnosis automatically eligible for Early Medical Diagnosis Name Other Names for the Diagnosis and Additional Diagnosis Information ACCESS? 6q terminal deletion syndrome Yes Achondrogenesis I Parenti-Fraccaro Yes Achondrogenesis II Langer-Saldino Yes Schinzel Acrocallosal syndrome; ACLS; ACS; Hallux duplication, postaxial polydactyly, and absence of the corpus Acrocallosal syndrome, Schinzel Type callosum Yes Acrodysplasia; Arkless-Graham syndrome; Maroteaux-Malamut syndrome; Nasal hypoplasia-peripheral dysostosis-intellectual disability syndrome; Peripheral dysostosis-nasal hypoplasia-intellectual disability (PNM) Acrodysostosis syndrome Yes ALD; AMN; X-ALD; Addison disease and cerebral sclerosis; Adrenomyeloneuropathy; Siemerling-creutzfeldt disease; Bronze schilder disease; Schilder disease; Melanodermic Leukodystrophy; sudanophilic leukodystrophy; Adrenoleukodystrophy Pelizaeus-Merzbacher disease Yes Agenesis of Corpus Callosum Absence of the corpus callosum; Hypogenesis of the corpus callosum; Dysplastic corpus callosum Yes Agenesis of Corpus Callosum and Chorioretinal Abnormality; Agenesis of Corpus Callosum With Chorioretinitis Abnormality; Agenesis of Corpus Callosum With Infantile Spasms And Ocular Anomalies; Chorioretinal Anomalies Aicardi syndrome with Agenesis Yes Alexander Disease Yes Allan Herndon syndrome Allan-Herndon-Dudley
    [Show full text]
  • Uniparental Disomy of the Entire X Chromosome in Turner Syndrome Patient-Specific Induced Pluripotent Stem Cells
    OPEN Citation: Cell Discovery (2015) 1, 15022; doi:10.1038/celldisc.2015.22 ARTICLE www.nature.com/celldisc Uniparental disomy of the entire X chromosome in Turner syndrome patient-specific induced pluripotent stem cells Yumei Luo*, Detu Zhu*, Rong Du, Yu Gong, Chun Xie, Xiangye Xu, Yong Fan, Bolan Yu, Xiaofang Sun, Yaoyong Chen Key Laboratory for Major Obstetric Diseases of Guangdong Province, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China The human induced pluripotent stem cell (iPSC) technique promises to provide an unlimited, reliable source of genetically matched pluripotent cells for personalized therapy and disease modeling. Recently, it is observed that cells with ring chromosomes 13 or 17 autonomously correct the defects via compensatory uniparental disomy during cellular reprogramming to iPSCs. This breakthrough finding suggests a potential therapeutic approach to repair large-scale chromosomal aberrations. However, due to the scarceness of ring chromosome samples, the reproducibility of this approach in different individuals is not carefully evaluated yet. Moreover, the underlying mechanism and the applicability to other types of chromosomal aberrations remain unknown. Here we generated iPSCs from four 45,X chorionic villous fibroblast lines and found that only one reprogrammed line acquired 46,XX karyotype via uniparental disomy of the entire X chromosome. The karyotype correction was reproducible in the same cell line by either retroviral or episomal reprogramming. The karyotype-corrected iPSCs were subject to X chromosome inactivation and obtained better colony morphology and higher proliferation rate than other uncorrected ones. Further transcriptomic comparison among the fibroblast lines identified a distinct expression pattern of cell cycle regulators in the uncorrectable ones.
    [Show full text]
  • Case Report Genetic Counseling for Trisomy X Syndrome Diagnosed By
    Acta Med. Nagasaki 64: 31−34− MS#AMN 07257 Case Report Genetic counseling for trisomy X syndrome diagnosed by amniocentesis: a case report Yuri HASEGAWA 1),2)*, Mikako MI Y ATA 2), Shoko MIURA 1),2), Ai NAGATA 1), Chiharu TO M O N AGA 1),2), Noriko SH IGETO M I 1), Kiyonori MIURA 1),2) 1) Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan 2) Department of Genetic Counseling, Nagasaki University Hospital, Nagasaki, Japan [Introduction] Trisomy X is a sex chromosome abnormality that occurs in approximately 1 in 1,000 female births. We provided genetic coun- seling to a pregnant woman and her husband following the prenatal diagnosis of trisomy X by amniocentesis. [Case] A 27-year-old pregnant woman, gravida 2, para 1, underwent a prenatal checkup by her general practitioner. Nuchal translu- cency (NT) of 3.4 mm was detected in the fetus at 11 weeks of gestation and had disappeared by 12 weeks of gestation. The pregnant woman and her husband consulted our unit for genetic counseling at 13 weeks of gestation. Although we did not detect any NT or other abnormality in the fetus, the parents were concerned about possible abnormalities and requested amniocentesis. Amniocentesis followed by chromosomal analysis at 16 weeks of gestation revealed a 47,XXX karyotype. We explained the results and characteristics of trisomy X to the couple. The frequency of trisomy X is 1 in 1,000, and it can be characterized by tall stature, developmental delay, learning disability, anxiety, and mood disorders. However, the features of trisomy X vary and we were therefore unable to predict the newborn’s precise postnatal physical and psychological character- istics.
    [Show full text]
  • Triple X Syndrome with a Rare Finding: Cleft Palate
    J Pediatr Res 2018;5(2):100-2 DO I: 10.4274/jpr.32154 Case Report Triple X Syndrome with a Rare Finding: Cleft Palate Esra Gürkaş1, Hülya Maraş Genç1, Esra Kılıç 2 1 University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Clinic of Pediatric Neurology, Ankara, Turkey 2 University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Clinic of Pediatric Genetics, Ankara, Turkey ABS TRACT Triple X syndrome (trisomy X) is a sex chromosomal anomaly caused by the presence of an extra X chromosome. The patients with Triple X syndrome have a wide range of phenotypic variability. Some individuals are only mildly affected or asymptomatic. Epicanthal folds, clinodactyly, tall stature and hypotonia are the most commom phenotypic features. Patients also may have seizures, genitourinary abnormalities and premature ovarian failure. We report a patient with Triple X syndrome and cleft palate. By describing this case, we want to draw attention to the association between cleft palate and Triple X syndrome. Keywords: Triple X, trisomy X, cleft palate, seizure Introduction Case Report Triple X syndrome (47,XXX) is a sex chromosomal A 11-year old girl was admitted to our neurology clinic abnormality. Affected females have an extra X chromosome. with seizure. She was the second child of healthy unrelated This syndrome was described by Jacobs et al. (1). Incidence parents. The age of mother at conception was 31 years old. is approximately 1/10.000 females (2). There is a wide There was no problem during the antenatal period and phenotypic variability of patients with triple X.
    [Show full text]